Abstract
Introduction

Atherosclerotic occlusion of blood vessels is a major cause of morbidity and mortality worldwide. Current treatment consists of percutaneous transluminal coronary angioplasty, stenting and coronary artery bypass graft [1]. Bypass grafting can be done using either internal mammary artery or saphenous vein (SV). However, stenosis and occlusion of SV conduits commonly limits long-term results following coronary bypass grafting (CABG) surgery
. The precise underlying mechanisms of intimal hyperplasia are likely to involve growth factors which promote hyperplasia, inflammation and mitogenesis, leading to progression of the cell cycle and proliferation of smooth muscle cells (SMCs) [3, 4] . [5] . [6, 7] . Angiotensin II (AT-II), a potent growth factor, has been shown to stimulate proliferation of vascular smooth muscle cells (VSMCs) , induce the migration of VSMCs, and induce the accumulation and deposition of collagen -all factors contributing to the pathogenesis of atherosclerosis [8, 9] . There is increasing evidence that connexins are involved in the development of intimal hyperplasia and restenosis involving mouse and human atherosclerotic lesions [10] . Recently, our data further showed that connexin43 (Cx43) expression can be influenced by AT-II [13] . 
Insulin-like growth factor-1 (IGF-1) is involved in protein synthesis, cell migration and mitogenesis. Increased expression of IGF-1 has also been shown in plaque and restenotic areas
Activation of IGF-1 receptors (IGF-1R) triggers several signal pathways, including phosphatidylinositol 3 kinase -Akt-and mitogen-activated protein kinase (MAPK)
Western blot analysis
Results
AT-II and IGF-1 signals cross-talk to up-regulate their reciprocal receptors
In our previous study, we showed that AT-II and IGF-1 increased protein expression of Cx43 in human SV SMCs in a dose-and time-dependent manner via AT-1R and IGF-1R, which may result in the increase in gap junction intercellular communication in
VSMCs [11] . Fig. 2A and B) . [11, 13] .
We further observed the effect of AT-II and IGF-1 on the Cx43 expression in SV SMCs in a cross-talk manner. Both IGF-1R and AT-1R were strongly expressed in either IGF-1 or AT-II stimulation. The presence of AT-II and IGF-1 together further increased the IGF-1R and AT-1R expression (Fig. 1).
We investigated the possible cross-talk signal between IGF-1 and AT-II that is involved in up-regulation of their reciprocal receptors. Initially, SMCs were transfected with siRNA against AT-1R or IGF-1R. The expression of AT-1R and IGF-1R was determined by Western blot analysis. A marked reduction of AT-1R and IGF-1R protein expression was present 48 and 72 hrs following siRNA treatment (lanes 3 and 4 of
IGF-1-induced AT-1R protein expression was also blocked by
Fig. 1 IGF-1 and AT-II induced the expression of IGF-1R and AT-1R in SV SMC. SV SMCs were treated with AT-II (10
. We found that AT-II and IGF-1-induced activation of transcription factor AP-1 in SV SMC (lanes 5 and 9 of Fig. 5A). However, both AT-II and IGF-1-induced activation of AP-1 were blocked by siRNA against IGF-1R, AT-1R and Erk
⁄ 2 (lanes 6-8, 10-12 of Fig. 5A). These data suggest that AT-II and IGF-induce the activation of transcription factor AP-through their reciprocal receptors and Erk 1/2 signalling pathways in SV SMCs. In order to confirm the involvement and activation of transcription factor AP-in AT-II and IGF-1-induced Cx43 expression, SMCs were co-transfected with pAP-1-Luc and A-Fos. In our previous data, we have confirmed that the A-Fos significantly blocked AT-II-induced activation of transcription factor AP-[11]. In this study, we further found that A-Fos markedly inhibited AT-II and IGF-1-induced Cx43 protein (lanes 4 and 6 of Fig. 5B). These results demonstrate that AT-II and IGF-induce the Cx43 expression via activation of transcription factor AP-through their reciprocal receptors in SV SMCs.
Fig. 2 Effect of AT-II and IGF-1 on the protein expression of AT-1R and IGF-1R in SV
In the present research, we further studied the effect of AT-II and IGF-1 on the Cx43 expression via up-regulation of their reciprocal receptors and downstream activation of MAPKs and AP-1 in SMCs of human SV. First, AT-II and IGF-1 induced the expression of AT-1R and IGF-1R via cross-talk signalling between AT-II and IGF-1 in SV SMCs. Secondly, AT-II and IGF-1 induced the activation of MAPKs, subsequently activating the transcription factor AP-1 in SV SMCs. Finally, AT-1R, IGF-1R, Erk 1/2 and AP-1 were involved in AT-II and IGF-1-induced Cx43 expression. These data demonstrate a cross-talk between IGF-1R and AT-1R in AT-II and IGF-1-induced Cx43 expression in SV SMCs involving phosphorylation of Erk 1/2 and downstream activation of AP-1 signalling pathway. Initiation and progression of the restenotic vessel involve complex patterns of interaction between the cells of the arterial wall, in
which cytokines, chemokines and growth factors are known to play a critical role [16] . Two strong mitogens and chemoattractants for SMCs are IGF-1 and AT-II, which elicit their effect via IGF-1R and AT-1R, respectively [16, 17] . Both IGF-1 and AT-II are abundantly present in restenotic human atherectomy specimens. We and others have reported the potent proliferative effect of IGF-1 and AT-II on VSMCs [18, 19] . In this study, we found that both [20, 21] [22] . Overexpression of AT-1R, for example by either oestrogen deficiency or hypercholesterolemia, enhances vasoconstriction, cell growth and production of reactive oxygen species. [20] . In our study, IGF-1 causes AT-1R up-regulation via activation of p42/44 MAPK. Studies also showed that other growth factors, such as platelet derived growth factor and basic fibroblast growth factor, could affect the AT-1R expression through phosphorylation of tyrosine [23] . IGF-1R is a critical determinant of VSMC growth response [24] . Thus, a functional IGF-1R autocrine loop is required for the mitogenic effects of vari- [11] . Many of the signalling events relevant to cell proliferation and differentiation are mediated through activation of transcription factors via MAPKs [27] . In our previous study, we have showed that activation of the ERK, p38 and JNK signalling pathways may participate in the regulation of cardiac gap junctions [11] . Gap junctions consist of aggregates of transmembrane hemichannels (or connexons) that link the cytoplasmic compartments of neighbouring cells, allowing a direct exchange of ions and second messengers [28] . Cx43 has been reported to be expressed in the vascular wall SMCs of the media, with Cx43 being predominant [29, 30] . Gap junctions have been described in cardiovascular disease [31] . Here [33] . The AP-1 and its promoter site are likely involved in the cytokine regulation of Cx43 [34] . Activation of ERK1/2 induces overexpression of c-fos mRNA and enhanced AP-1 DNA-binding activity [35] . We 
IGF-1 and AT-II up-regulated their reciprocal receptors. AT-1R activation plays a pivotal role in the pathogenesis of hypertension, atherosclerosis and heart failure. Stimulation of AT-1R by AT-II leads to increasing sympathetic activity, vasoconstriction, reabsorption of water and sodium, cellular growth and apoptosis, and to the accelerated progression of atherosclerosis
. Inhibition of AT-1R activation by angiotensin converting enzyme inhibition or AT-1R antagonism resulting in blood pressure reduction in hypertensive patients decreases proliferation of SMCs after cardiac interventional surgery with stent and angioplasty, and attenuates the onset and progression of atherosclerosis
